Whole-genome sequencing of SARS-CoV-2 from residual viral RNA present on positive rapid antigen test kits for genomic surveillance
- PMID: 40171102
- PMCID: PMC11957951
- DOI: 10.5365/wpsar.2025.16.1.1140
Whole-genome sequencing of SARS-CoV-2 from residual viral RNA present on positive rapid antigen test kits for genomic surveillance
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
Similar articles
-
Inactivation and Recovery of High Quality RNA From Positive SARS-CoV-2 Rapid Antigen Tests Suitable for Whole Virus Genome Sequencing.Front Public Health. 2022 May 3;10:863862. doi: 10.3389/fpubh.2022.863862. eCollection 2022. Front Public Health. 2022. PMID: 35592078 Free PMC article.
-
Non-SARS-CoV-2 respiratory viral detection and whole genome sequencing from COVID-19 rapid antigen test devices: a laboratory evaluation study.Lancet Microbe. 2024 Apr;5(4):e317-e325. doi: 10.1016/S2666-5247(23)00375-0. Epub 2024 Feb 12. Lancet Microbe. 2024. PMID: 38359857
-
The Suitability of RNA from Positive SARS-CoV-2 Rapid Antigen Tests for Whole Virus Genome Sequencing and Variant Identification to Maintain Genomic Surveillance.Diagnostics (Basel). 2023 Dec 7;13(24):3618. doi: 10.3390/diagnostics13243618. Diagnostics (Basel). 2023. PMID: 38132202 Free PMC article.
-
SARS-CoV-2 molecular testing and whole genome sequencing following RNA recovery from used BinaxNOW COVID-19 Antigen Self Tests.medRxiv [Preprint]. 2023 Jan 9:2023.01.09.23284337. doi: 10.1101/2023.01.09.23284337. medRxiv. 2023. Update in: J Clin Virol. 2023 May;162:105426. doi: 10.1016/j.jcv.2023.105426. PMID: 36712132 Free PMC article. Updated. Preprint.
-
Using SARS-CoV-2 Sequencing Data to Identify Reinfection Cases in the Global Emerging Infections Surveillance Program, United States.Emerg Infect Dis. 2024;30(14):53-61. doi: 10.3201/eid3014.240231. Emerg Infect Dis. 2024. PMID: 39530855 Free PMC article. Review.
References
-
- Petersen E, Ntoumi F, Hui DS, Abubakar A, Kramer LD, Obiero C, et al. Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa’s research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts. Int J Infect Dis. 2022. Jan;114:268–72. 10.1016/j.ijid.2021.11.040 - DOI - PMC - PubMed
-
- Azami NAM, Perera D, Thayan R, AbuBakar S, Sam IC, Salleh MZ, et al.; Malaysia COVID-19 Genomics Surveillance Consortium. SARS-CoV-2 genomic surveillance in Malaysia: displacement of B.1.617.2 with AY lineages as the dominant Delta variants and the introduction of Omicron during the fourth epidemic wave. Int J Infect Dis. 2022. Dec;125:216–26. 10.1016/j.ijid.2022.10.044 - DOI - PMC - PubMed
-
- Antigen-detection in the diagnosis of SARS-CoV-2 infection: interim guidance, 6 October 2021. Geneva: World Health Organization; 2021. Available from: https://iris.who.int/handle/10665/345948, accessed 6 January 2024.
-
- Ng DLC, Bin Jamalludin MA, Gan XY, Ng SY, Bin Mohamad Rasidin MZ, Felix BA, et al. Public’s willingness to perform COVID-19 self-testing during the transition to the endemic phase in Malaysia – a population-based cross-sectional study. Risk Manag Healthc Policy. 2023. Nov 21;16:2505–19. 10.2147/RMHP.S439530 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous